10 research outputs found
Angioscopic Evaluation of Stabilizing Effects of Bezafibrate on Coronary Plaques in Patients With Coronary Artery Disease
Get PDFBackground Since long-term administrations of anti-hyperlipidemic
agents result in reduction in % stenosis or increase in
minimum lumen diameter (MLD) of stenotic coronary
segments, it is generally believed that anti-hyperlipidemic agents
stabilize vulnerable coronary plaques. However, recent pathologic
and angioscopic studies revealed that vulnerability of coronary
plaques is not related to severity of stenosis and the rims rather
than top of the plaques disrupt, and therefore, angiography is not
adequate for evaluation of vulnerability
Extensive deep vein thrombosis treatment using fondaparinux and edoxaban: a case report
Full text linkA Randomized Controlled Study to Compare the Effects of Rosuvastatin 2.5mg and Pravastatin10mg on the Plasma Lipid Profile in Japanese Patients with Hypercholesterolemia (ASTRO-1)
No full textAdditional file 3: of Extensive deep vein thrombosis treatment using fondaparinux and edoxaban: a case report
No full textUltrasonography (Aplio XG, Toshiba) images of the left lower extremity after 6Ă‚Â months of treatment. (JPG 38Ă‚Â kb
Additional file 2: of Extensive deep vein thrombosis treatment using fondaparinux and edoxaban: a case report
No full textUltrasonography (Noblus, Hitachi Aloka Medical) images of the left lower extremity after 3Ă‚Â months of treatment. (JPG 53Ă‚Â kb
Two Cases of Brugada Syndrome Associated With Spontaneous Clinical Episodes of Coronary Vasospasm
No full text
